Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT (UNAUDITED)

v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT (UNAUDITED) - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2020 $ 6 $ 674,906 $ (695,325) $ (20,413)
Beginning, balance shares at Dec. 31, 2020 59,710,047      
Net loss (13,549) (13,549)
Proceeds from sale of Series H preferred stock and warrants, net of issuance costs 653 653
Share-based compensation expense 661 661
Ending balance, value at Mar. 31, 2021 $ 6 676,220 (708,874) (32,648)
Ending, balance shares at Mar. 31, 2021 59,710,047      
Net loss (10,418) (10,418)
Exercise of common stock options 69 69
Exercise of common stock options, shares 14,277      
Share-based compensation expense 828 828
Ending balance, value at Jun. 30, 2021 $ 6 677,117 (719,292) (42,169)
Ending, balance shares at Jun. 30, 2021 59,724,324      
Beginning balance, value at Dec. 31, 2021 $ 7 749,592 (765,851) (16,252)
Beginning, balance shares at Dec. 31, 2021 72,335,952      
Net loss (29,738) (29,738)
Share-based compensation expense 6,564 6,564
Ending balance, value at Mar. 31, 2022 $ 7 756,156 (795,589) (39,426)
Ending, balance shares at Mar. 31, 2022 72,335,952      
Beginning balance, value at Dec. 31, 2021 $ 7 749,592 (765,851) (16,252)
Beginning, balance shares at Dec. 31, 2021 72,335,952      
Ending balance, value at Jun. 30, 2022 $ 7 763,128 (816,606) (53,471)
Ending, balance shares at Jun. 30, 2022 72,335,952      
Beginning balance, value at Mar. 31, 2022 $ 7 756,156 (795,589) (39,426)
Beginning, balance shares at Mar. 31, 2022 72,335,952      
Net loss (21,017) (21,017)
Share-based compensation expense 6,972 6,972
Ending balance, value at Jun. 30, 2022 $ 7 $ 763,128 $ (816,606) $ (53,471)
Ending, balance shares at Jun. 30, 2022 72,335,952